Soc. Generale Knock-Out ABT/ DE000SW1F414 /
06/11/2024 17:49:55 | Chg.+0.170 | Bid18:06:58 | Ask18:06:58 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.460EUR | +5.17% | 3.470 Bid Size: 70,000 |
3.480 Ask Size: 70,000 |
Abbott Laboratories | 153.635 USD | 31/12/2078 | Put |
GlobeNewswire
06/08
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
06/06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15/03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14/11/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19/10/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer